CAMP
CAMP4 THERAPEUTICS CORPORATION
4.00$
+4.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
CAMP4 THERAPEUTICS CORPORATION (CAMP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -30 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.3 | 3.0 | 6.0 | 0.3 | 7.5 | 12 | 5.5 | 5.1 | 13 | 22 | 17 | -1.5 | 14 | 2.5 | 0.9 | 12 | 17 | 23 | 29 | 47 | 26 | 67 | 48 | 12 | 29 | -4.2 | -39 | -44 | -46 | -30 | |
| 2.0 | 3.3 | 3.0 | 3.0 | 4.3 | 4.3 | 3.7 | 3.4 | 4.3 | 4.4 | 6.9 | 9.7 | 6.5 | 2.5 | 3.1 | 2.4 | 2.8 | 8.1 | 9.4 | 10 | 23 | 23 | 9.8 | 23 | 22 | 23 | 0.9 | 1.7 | 1.7 | 1.6 | |
| – | – | -0.2 | – | – | – | – | – | – | – | 0.1 | 0.9 | 1.3 | 2.0 | 2.1 | 2.4 | 2.9 | 2.9 | 4.1 | 5.9 | 7.8 | 9.3 | 9.5 | 11 | 11 | 11 | 1.4 | 2.9 | 4.0 | 4.0 | |
| -7.9 | 2.1 | 4.3 | -8.2 | -5.0 | 2.1 | -5.9 | -4.7 | -5.1 | -4.3 | 1.0 | 19 | 7.5 | 7.7 | -1.8 | 0.8 | -7.3 | -15 | -16 | 6.1 | -2.0 | -9.8 | -25 | 3.7 | 11 | 1.6 | 0.4 | -0.2 | -1.9 | 13 | |
| 3.4 | 2.8 | 1.3 | 5.4 | 4.3 | 1.5 | 1.7 | 2.7 | 2.4 | 2.3 | 2.8 | 1.4 | 0.8 | 1.1 | 1.2 | 1.1 | 1.9 | 2.1 | 7.4 | 4.3 | 8.0 | 8.3 | 10 | 21 | 11 | 13 | 4.0 | 0.7 | 0.4 | 0.3 | |
| -3.4 | -2.4 | -0.4 | -12 | -4.3 | 1.5 | -18 | -0.5 | -2.4 | -7.0 | -53 | -24 | -1.4 | 0.2 | -0.8 | -0.5 | -2.4 | -64 | -8.7 | -91 | -46 | -26 | -22 | -66 | -14 | -7.6 | -4.0 | -0.7 | -0.4 | -0.2 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -25 | – | -49 | -49 | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.1 | -0.3 | -0.4 | -0.1 | |
| 0.3 | 0.6 | -0.7 | 5.0 | 4.5 | -0.5 | 11 | -3.7 | -2.0 | -0.6 | 28 | -6.5 | -11 | -6.8 | 1.2 | -11 | 43 | -2.5 | -5.0 | 148 | -26 | -2.3 | 98 | -95 | -27 | -2.6 | 100 | 0.3 | 72 | 76 | |
| -8.4 | 1.2 | 4.9 | -6.2 | 7.2 | 13 | -1.2 | 0.9 | 8.2 | 15 | -8.2 | -31 | 0.3 | -3.9 | 1.3 | 1.4 | 63 | -44 | 15 | 105 | -46 | 39 | 124 | -149 | -13 | -15 | 83 | -45 | 26 | 46 | |
| -8.7 | 0.2 | 4.7 | -5.1 | 3.2 | 11 | 3.8 | 2.4 | 10 | 20 | 14 | -2.8 | 13 | 1.4 | -0.4 | 11 | 15 | 21 | 21 | 43 | 18 | 59 | 37 | -9.8 | 17 | -18 | -43 | -45 | -46 | -30 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.